DE2343570A1 - Pharmazeutische mittel zur oralen verabreichung - Google Patents

Pharmazeutische mittel zur oralen verabreichung

Info

Publication number
DE2343570A1
DE2343570A1 DE19732343570 DE2343570A DE2343570A1 DE 2343570 A1 DE2343570 A1 DE 2343570A1 DE 19732343570 DE19732343570 DE 19732343570 DE 2343570 A DE2343570 A DE 2343570A DE 2343570 A1 DE2343570 A1 DE 2343570A1
Authority
DE
Germany
Prior art keywords
stomach
tge
means according
microparticles
enteric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19732343570
Other languages
German (de)
English (en)
Inventor
Angel S Arambulo
Deam H Ferris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois
Original Assignee
University of Illinois
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US00285036A external-priority patent/US3823228A/en
Application filed by University of Illinois filed Critical University of Illinois
Publication of DE2343570A1 publication Critical patent/DE2343570A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A61K39/225—Porcine transmissible gastroenteritis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19732343570 1972-08-30 1973-08-29 Pharmazeutische mittel zur oralen verabreichung Pending DE2343570A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00285036A US3823228A (en) 1971-09-29 1972-08-30 Tge virus vaccine

Publications (1)

Publication Number Publication Date
DE2343570A1 true DE2343570A1 (de) 1974-03-14

Family

ID=23092469

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732343570 Pending DE2343570A1 (de) 1972-08-30 1973-08-29 Pharmazeutische mittel zur oralen verabreichung

Country Status (9)

Country Link
JP (1) JPS535371B2 (US20110009641A1-20110113-C00116.png)
AR (1) AR197158A1 (US20110009641A1-20110113-C00116.png)
AU (1) AU5949773A (US20110009641A1-20110113-C00116.png)
CA (1) CA1023266A (US20110009641A1-20110113-C00116.png)
DE (1) DE2343570A1 (US20110009641A1-20110113-C00116.png)
FR (1) FR2197576B1 (US20110009641A1-20110113-C00116.png)
GB (1) GB1440214A (US20110009641A1-20110113-C00116.png)
NL (1) NL7312032A (US20110009641A1-20110113-C00116.png)
PH (1) PH10296A (US20110009641A1-20110113-C00116.png)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0009577A1 (en) * 1978-08-18 1980-04-16 Burns-Biotec Laboratories Inc. An oral vaccine preparation and a method for increasing the resistance of swine to swine-dysentery infection
JPS584561Y2 (ja) * 1980-11-26 1983-01-26 日本濾過器株式会社 気泡分離装置
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
US6024983A (en) * 1986-10-24 2000-02-15 Southern Research Institute Composition for delivering bioactive agents for immune response and its preparation
DE19741114C2 (de) * 1997-09-12 2002-10-24 Riemser Arzneimittel Ag Feuchtigkeitsstabile und magensaftresistente Arzneiform für Fische

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458621A (en) * 1966-08-31 1969-07-29 American Home Prod Tablet dosage-form for the immunization of the intestinal tract with live virus preparations
US3519710A (en) * 1967-08-10 1970-07-07 Edmund P Bass Direct active modified live virus vaccine immunization against transmissible gastroenteritis in swine piglets at birth

Also Published As

Publication number Publication date
JPS535371B2 (US20110009641A1-20110113-C00116.png) 1978-02-27
FR2197576A1 (US20110009641A1-20110113-C00116.png) 1974-03-29
FR2197576B1 (US20110009641A1-20110113-C00116.png) 1976-09-03
AU5949773A (en) 1975-02-27
NL7312032A (nl) 1975-03-04
GB1440214A (en) 1976-06-23
AR197158A1 (es) 1974-03-15
JPS4962618A (US20110009641A1-20110113-C00116.png) 1974-06-18
CA1023266A (en) 1977-12-27
PH10296A (en) 1976-11-10

Similar Documents

Publication Publication Date Title
US3823228A (en) Tge virus vaccine
Anderson et al. Effects of a series of infections of Ostertagia circumcincta on gastric secretion of sheep
DE2343570A1 (de) Pharmazeutische mittel zur oralen verabreichung
EP1083907B1 (en) Control of parasitic infestations in farmed and wild fish
Quin et al. Studies on the photosensitisation of animals in South Africa. VIII. The biological formation of phylloerythrin in the digestive tracts of various domesticated animals
BR112020004650B1 (pt) Uso de raízes ou folhas de chicória para proteger gado, animais de estimação e aves contra ectoparasitas, ou como repelente de insetos
EP1853308B1 (de) Pharmazeutisches, oral applizierbares präparat zur behandlung von fischen, herstellungsverfahren für dieses und seine verwendung
DE2360118C3 (de) Impfstoff gegen Ferkel-Colibacillose
DE3034238A1 (de) Impfstoff zur bekaempfung der newcastle-krankheit und verfahren zur herstellung derselben
Maghami External parasites of livestocks in Iran
DE3878063T2 (de) Resorcylsaeure-lacton-verbindungen zur bekaempfung von helminthes-parasiten.
JPH08259462A (ja) 抗パルボウイルス感染症組成物
WO1999013869A1 (de) Feuchtigkeitsstabile und magensaftresistente arzneiformen für tiere
DE1253412B (de) Verfahren zur Gewinnung eines Impfstoffes gegen infektioese Schweinegastroenteritis
EA001623B1 (ru) Соединения из класса ацилмочевин, предназначенные для лечения кокцидиоидомикоза у теплокровных животных
DE2262139A1 (de) Arzneimittel zur bekaempfung von endoparasiten
CN112641723B (zh) 一种治疗耳螨的药物组合物及其制备方法
DE2057544A1 (de) Verfahren zur Herstellung einer Virusvakzine gegen das Kaelberdiarrhoevirus
DE2754701A1 (de) Verfahren zur bekaempfung der entwicklung von fliegen im mist von warmbluetern
Hall Parasites and parasitic diseases of sheep
Gill Anaplasmosis in beef cattle
RU2152220C1 (ru) Способ профилактики диареи
Young The diagnosis and control of game diseases
DE2159588C2 (de) Verfahren zum Herstellen eines Impfstoffs für Rinder
DE1767882A1 (de) Vakzin und Verfahren zur Verhinderung der uebertragbaren Gastroenteritis bei Schweinen

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee